New Zealand MEDSAFE grants approval for Invex’s IIH therapy trial
Approvals
Exscientia receives approval to begin advanced solid tumour therapy trial
The trail will assess EXS-21546 along with anti-PD-1 therapy in relapsed or refractory RCC and NSCLC patients.
Taiho Oncology’s Lytgobi granted accelerated approval in cholangiocarcinoma
EMA qualifies Unlearn’s AI-driven approach for smaller trials
Looming Amylyx drug approval decision renews debate over ALS endpoints
FDA grants IND clearance for Eledon’s tegoprubart to treat IgA Nephropathy
US FDA grants IND clearance for Aston Sci.’s Phase II cancer vaccine trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
